U.S. Bioscience regulatory update

CPMP unanimously recommended NeuTrexin for use with concurrent leucovorin administration as an alternative therapy for moderate-to-severe PCP in patients with AIDS who are intolerant of, or refractory to, standard therapy, or for whom standard therapy is contraindicated. ...